Prolactin Hormone in Oral Lichen Planus
Sponsor
October University for Modern Sciences and Arts (Other)
Overall Status
Completed
CT.gov ID
NCT04785703
Collaborator
Al-Azhar University (Other)
40
1
5.7
7
Study Details
Study Description
Brief Summary
Oral lichen planus (OLP) is one of the most common mucosal diseases with autoimmune etio-pathogenesis with involvement of various cytokines similar to psoriasis.It generally occurs more commonly in females, in a ratio of 3:2. prolactin (PRL),It is a peptide hormone that has a role in autoimmune related diseases like systemic lupus erythematosus and , rheumatoid Artheritis. The role of PrL in OLP pathogenesis was never investigated.the aim of this study is to investigate the expression of PRL receptors in tissue biopsies of OLP patients.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
40 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Prolactin Hormone in Oral Lichen Planus Tissue Samples
Actual Study Start Date
:
Jun 19, 2020
Actual Primary Completion Date
:
Aug 22, 2020
Actual Study Completion Date
:
Dec 10, 2020
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
oral lichen planus group patients with chronic bollus erosive lichen planus |
Outcome Measures
Primary Outcome Measures
- prolactin receptors expression in oral mucous membrane [24 hours]
immuno-histochemistry
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
patients with oral lichen planus
-
systemically healthy
Exclusion Criteria:
- oral lichenoid lesions
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | October University for modern sciences and arts | Giza | Egypt |
Sponsors and Collaborators
- October University for Modern Sciences and Arts
- Al-Azhar University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Naglaa Elwakeel,
professor,
October University for Modern Sciences and Arts
ClinicalTrials.gov Identifier:
NCT04785703
Other Study ID Numbers:
- REC18-048
First Posted:
Mar 8, 2021
Last Update Posted:
Mar 8, 2021
Last Verified:
Mar 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: